Displaying 201 - 225 of 1557
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CD7
Methodology
Immunohistochemistry (IHC)
Test Description
CD7 is expressed on the majority of immature and mature T-lymphocytes and T-cell leukemia. It is also found on natural killer cells, and a…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CD71
Methodology
Immunohistochemistry (IHC)
Test Description
CD71 is useful in identifying erythroid precursors with no interference from mature erythrocytes and also in the determination of erythroid…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CD79a
Methodology
Immunohistochemistry (IHC)
Test Description
CD79a first appears at the pre B-cell stage and persists until the plasma cell stage where it is found as an intracellular component.…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CD8
Methodology
Immunohistochemistry (IHC)
Test Description
CD8 is a T-cell marker for the detection of cytotoxic/suppressor T-cells. CD8 is also detected on NK cells, most thymocytes, a subpopulation…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CD99
Methodology
Immunohistochemistry (IHC)
Test Description
CD99 (MIC2 gene product, E2) antigen is strongly expressed by Ewing sarcoma cells, primitive peripheral neuroectodermal tumors, and…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CDK4
Methodology
Immunohistochemistry (IHC)
Test Description
Among cyclin/CDK proteins, CDK4 and cyclin D1 are the most frequently activated by somatic genetic alterations in multiple tumor types.…
Source:
Test
Methodology:
FISH
CDKN2A/B (p16) Deletion FISH for ALL
Methodology
FISH
Test Description
Probes: CDKN2A/B (p16) (9p21) | Centromere 9 Disease(s): Acute Lymphoblastic Leukemia (ALL)
Clinical…
Source:
Test
Methodology:
FISH
CDKN2A/B (p16) Deletion for Mesothelioma or Glioma
Methodology
FISH
Test Description
Probes: CDKN2A/B (p16) (9p21) | Centromere 9Disease(s): Mesothelioma, Glioma
Clinical…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CDX2
Methodology
Immunohistochemistry (IHC)
Test Description
CDX2 is an intestine specific transcription factor that regulates both the proliferation and differentiation of intestinal epithelial cells…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CDX2/CK7 Double Stain
Methodology
Immunohistochemistry (IHC)
Test Description
CDX2 is a transcription factor expressed in the nuclei of epithelial cells throughout the intestine, from duodenum to…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CEA (Mono)
Alternative Name
CEA monoclonal
Methodology
Immunohistochemistry (IHC)
Test Description
Carcinoembryonic antigen (CEA) is usually demonstrated as a linear…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CEA (Poly)
Alternative Name
CEA polyclonal
Methodology
Immunohistochemistry (IHC)
Test Description
Polyclonal carcinoembryonic antigen (CEA) antibody stains a larger…
Source:
Test
Methodology:
Molecular
CEBPA Mutation Analysis
Alternative Name
CEBPA
Methodology
Molecular
Test Description
Fragment length analysis of the relevant coding region for detection of sequence…
Source:
Test
Methodology:
Molecular
Cholangio/Pancreatic Carcinoma NGS Fusion Panel
Methodology
Molecular
Test Description
The Cholangio/Pancreatic Carcinoma NGS Fusion Panel is an RNA-based next-generation sequencing panel that detects…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
Chromogranin A
Methodology
Immunohistochemistry (IHC)
Test Description
Chromogranin is present in several elements of the diffuse neuroendocrine system (DNES), including anterior pituitary, thyroid…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK HMW (CK903/34BE12)
Methodology
Immunohistochemistry (IHC)
Test Description
CK903 (34betaE12) is a high molecular weight cytokeratin present in all squamous epithelium and their carcinomas. This…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK HMW/CK LMW Double Stain
Methodology
Immunohistochemistry (IHC)
Test Description
This cytokeratin cocktail can be useful in differentiation of the squamous cell carcinomas and adenocarcinomas. The…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK OSCAR
Alternative Name
CK OSCAR (Pan Cytokeratin)
Methodology
Immunohistochemistry (IHC)
Test Description
Anti-cytokeratin clone OSCAR (CK OSCAR) demonstrates a…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK14 (Cytokeratin 14)
Methodology
Immunohistochemistry (IHC)
Test Description
Cytokeratin 14 (CK14) belongs to the type A (acidic) subfamily of high molecular weight keratins and exists in combination…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK17
Alternative Name
Cytokeratin 17
Methodology
Immunohistochemistry (IHC)
Test Description
Cytokeratin 17 (CK17) is an effective marker to distinguish myoepithelial…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK18 (Cytokeratin 18)
Methodology
Immunohistochemistry (IHC)
Test Description
Cytokeratin 18 (CK 18), a 45kDa protein, belongs to the acidic type of cytokeratins, and is typically expressed in simple…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK19
Alternative Name
Cytokeratin 19
Methodology
Immunohistochemistry (IHC)
Test Description
Cytokeratin 19 (CK19) is a member of the type I acidic subfamily of…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK20
Alternative Name
Cytokeratin 20
Methodology
Immunohistochemistry (IHC)
Test Description
Cytokeratin 20 (CK20) positivity is seen in the majority of…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK5/6
Alternative Name
Cytokeratin 5/6
Methodology
Immunohistochemistry (IHC)
Test Description
D5/16 B4 clone of CK5/6 antibody reacts strongly with cytokeratins 5 and…
Source:
Test
Methodology:
Immunohistochemistry (IHC)
CK7
Alternative Name
Cytokeratin 7
Methodology
Immunohistochemistry (IHC)
Test Description
Cytokeratin 7 (CK7) antibody reacts with proteins that are found in most…